Sandostatin (octreotide acetate).
Sandostatin is an antineoplastic drug used to control diarrhea and improve hypokalema in patients with metastatic carcinoid tumors and vasoactive intestinal peptide-secreting tumors. Sandostatin has been used to treat life-threatening hypotension and acromegaly. Sandostatin has also been used after endoscopic retrograde cholangiopancreatography to reduce the motility of the pancreas. Generally side effects of Sandostatin are rare and medically manageable when recognized. Chronic therapy with Sandostatin warrants monitoring of serum electrolyte and blood glucose levels. Baseline thyroid studies should be investigated prior to therapy and monitored throughout therapy. Sandostatin may alter fat absorption and gallbladder function; therefore, monitoring of appropriate laboratory values and ultrasonography studies may also be indicated.
Claussen
D
D
D006801:Humans; D015282:Octreotide / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010353:Patient Education as Topic
D015282:Octreotide